Cargando…
Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195381/ https://www.ncbi.nlm.nih.gov/pubmed/30349655 http://dx.doi.org/10.18632/oncotarget.26213 |
| _version_ | 1783364383291736064 |
|---|---|
| author | Cazzaniga, Marina Verusio, Claudio Ciccarese, Mariangela Fumagalli, Alberto Sartori, Donata Valerio, Maria Rosaria Airoldi, Mario Moretti, Gabriella Ficorella, Corrado Arcangeli, Valentina Diodati, Lucrezia Zambelli, Alberto Febbraro, Antonio Generali, Daniele Pistelli, Mirco Garrone, Ornella Musolino, Antonino Vici, Patrizia Maur, Michela Mentuccia, Lucia La Verde, Nicla Bianchi, Giulia Artale, Salvatore Blasi, Livio Piezzo, Matilde Atzori, Francesco Turletti, Anna Benedetto, Chiara Cursano, Maria Concetta Fabi, Alessandra Gebbia, Vittorio Schirone, Alessio Palumbo, Raffaella Ferzi, Antonella Frassoldati, Antonio Scavelli, Claudio Clivio, Luca Torri on behalf of The EVA Study Group, Valter |
| author_facet | Cazzaniga, Marina Verusio, Claudio Ciccarese, Mariangela Fumagalli, Alberto Sartori, Donata Valerio, Maria Rosaria Airoldi, Mario Moretti, Gabriella Ficorella, Corrado Arcangeli, Valentina Diodati, Lucrezia Zambelli, Alberto Febbraro, Antonio Generali, Daniele Pistelli, Mirco Garrone, Ornella Musolino, Antonino Vici, Patrizia Maur, Michela Mentuccia, Lucia La Verde, Nicla Bianchi, Giulia Artale, Salvatore Blasi, Livio Piezzo, Matilde Atzori, Francesco Turletti, Anna Benedetto, Chiara Cursano, Maria Concetta Fabi, Alessandra Gebbia, Vittorio Schirone, Alessio Palumbo, Raffaella Ferzi, Antonella Frassoldati, Antonio Scavelli, Claudio Clivio, Luca Torri on behalf of The EVA Study Group, Valter |
| author_sort | Cazzaniga, Marina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6195381 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-61953812018-10-22 Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study Cazzaniga, Marina Verusio, Claudio Ciccarese, Mariangela Fumagalli, Alberto Sartori, Donata Valerio, Maria Rosaria Airoldi, Mario Moretti, Gabriella Ficorella, Corrado Arcangeli, Valentina Diodati, Lucrezia Zambelli, Alberto Febbraro, Antonio Generali, Daniele Pistelli, Mirco Garrone, Ornella Musolino, Antonino Vici, Patrizia Maur, Michela Mentuccia, Lucia La Verde, Nicla Bianchi, Giulia Artale, Salvatore Blasi, Livio Piezzo, Matilde Atzori, Francesco Turletti, Anna Benedetto, Chiara Cursano, Maria Concetta Fabi, Alessandra Gebbia, Vittorio Schirone, Alessio Palumbo, Raffaella Ferzi, Antonella Frassoldati, Antonio Scavelli, Claudio Clivio, Luca Torri on behalf of The EVA Study Group, Valter Oncotarget Correction Impact Journals LLC 2018-10-02 /pmc/articles/PMC6195381/ /pubmed/30349655 http://dx.doi.org/10.18632/oncotarget.26213 Text en Copyright: © 2018 Cazzaniga et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Correction Cazzaniga, Marina Verusio, Claudio Ciccarese, Mariangela Fumagalli, Alberto Sartori, Donata Valerio, Maria Rosaria Airoldi, Mario Moretti, Gabriella Ficorella, Corrado Arcangeli, Valentina Diodati, Lucrezia Zambelli, Alberto Febbraro, Antonio Generali, Daniele Pistelli, Mirco Garrone, Ornella Musolino, Antonino Vici, Patrizia Maur, Michela Mentuccia, Lucia La Verde, Nicla Bianchi, Giulia Artale, Salvatore Blasi, Livio Piezzo, Matilde Atzori, Francesco Turletti, Anna Benedetto, Chiara Cursano, Maria Concetta Fabi, Alessandra Gebbia, Vittorio Schirone, Alessio Palumbo, Raffaella Ferzi, Antonella Frassoldati, Antonio Scavelli, Claudio Clivio, Luca Torri on behalf of The EVA Study Group, Valter Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title | Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title_full | Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title_fullStr | Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title_full_unstemmed | Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title_short | Correction: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study |
| title_sort | correction: everolimus (eve) and exemestane (exe) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the eva study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195381/ https://www.ncbi.nlm.nih.gov/pubmed/30349655 http://dx.doi.org/10.18632/oncotarget.26213 |
| work_keys_str_mv | AT cazzanigamarina correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT verusioclaudio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT ciccaresemariangela correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT fumagallialberto correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT sartoridonata correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT valeriomariarosaria correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT airoldimario correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT morettigabriella correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT ficorellacorrado correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT arcangelivalentina correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT diodatilucrezia correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT zambellialberto correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT febbraroantonio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT generalidaniele correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT pistellimirco correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT garroneornella correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT musolinoantonino correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT vicipatrizia correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT maurmichela correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT mentuccialucia correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT laverdenicla correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT bianchigiulia correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT artalesalvatore correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT blasilivio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT piezzomatilde correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT atzorifrancesco correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT turlettianna correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT benedettochiara correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT cursanomariaconcetta correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT fabialessandra correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT gebbiavittorio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT schironealessio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT palumboraffaella correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT ferziantonella correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT frassoldatiantonio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT scavelliclaudio correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT clivioluca correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy AT torrionbehalfoftheevastudygroupvalter correctioneverolimuseveandexemestaneexeinpatientswithadvancedbreastcanceraged65yearsnewlessonsforclinicalpracticefromtheevastudy |